Modulation of interleukin-1 receptors followed by endotoxin lipopolysaccharide treatment in the mouse AtT-20 pituitary tumor cell line

NeuroImmunoModulation

Volumn 10, Issue 5, 2002, Pages 310-316

  Kumagai, Chizuru ^a   Takao, Toshihiro ^a   Matsumoto, Reiko ^a   Asaba, Koichi ^a   Hashimoto, Kozo ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

AtT 20 cells; Interleukin 1 receptor; Lipopolysaccharide; Western blotting

Indexed keywords

ENDOTOXIN; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; HYPOPHYSIS TUMOR; IMMUNOBLOTTING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION; TUMOR CELL LINE; WESTERN BLOTTING;

ANIMALS; BINDING, COMPETITIVE; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; ENDOTOXEMIA; IMMUNOLOGIC FACTORS; INTERLEUKIN-1; LIPOPOLYSACCHARIDES; MALE; MICE; PITUITARY NEOPLASMS; RECEPTORS, INTERLEUKIN-1; RECOMBINANT FUSION PROTEINS;

EID: 0037679146     PISSN: 10217401     EISSN: None     Source Type: Journal    
DOI: 10.1159/000069975     Document Type: Article

References (41)

1. Dinarello CA: Biology of interleukin 1. FASEB J 1988;2:108-115.
2. Koenig JI, Snow K, Clark BD, Toni R, Cannon JG, Shaw AR, Dinarello CA, Reichlin S, Lee SL, Lechan RM: Intrinsic pituitary interleukin-1β is induced by bacterial lipopolysaccharide. Endocrinology 1990;126:3053-3058.
3. Higgins GA, Olschowka JA: Induction of interleukin-1β mRNA in adult rat brain. Mol Brain Res 1991;9:143-148.
4. Ban E, Haour F, Lenstra R: Brain interleukin 1 gene expression induced by peripheral lipopolysaccharide administration. Cytokine 1992;4:48-54.
5. Ohlsson K, Bjork P, Bergenfeldt M, Hageman R, Thompson RC: Interleukin-1 receptor antagonist reduces mortality from endotoxin shock. Nature 1990;348:550-552.
6. Rivier C, Chizzonite R, Vale W: In the mouse, activation of the hypothalamic-pituitary-adrenal axis by lipopolysaccharide (endotoxin) is mediated through interleukin-1. Endocrinology 1989;125:2800-2805.
7. Ebisui O, Fukata F, Tominaga T, Murakami N, Kobayashi H, Segawa H, Muro S, Naito Y, Nakai Y, Masui Y, Nishida T, Imura H: Role of interleukin-1α and 1β in endotoxin-induced suppression of plasma gonadotropin levels in rats. Endocrinology 1992;130:3307-3313.
8. Tracey KJ, Beutler B, Lowry SF, Merryweather J, Wolpe S, Milsark IW, Hariri RJ, Fahey III TJ, Zentella A, Albert JD, Shires GT, Cerami A: Shock and tissue injury induced by recombinant human cachectin. Science 1986;234:470-474.
9. Haour FG, Ban EM, Milon GM, Baran D, Fillion GM: Brain interleukin-1 receptors: Characterization and modulation after lipopolysaccharide injection. Prog NeuroEndocrinImmunol 1990;3:196-204.
10. Takao T, Mitchell WM, Tracey DE, De Souza EB: Identification of interleukin-1 receptors in mouse testis. Endocrinology 1990;127:251-258.
11. Takao T, Tracey DE, Mitchell WM, De Souza EB: Interleukin-1 receptors in mouse brain: Characterization and neuronal localization. Endocrinology 1990;127:3070-3078.
12. 125I-recombinant human IL-1 receptor antagonist. J Neuroimmunol 1992;41:51-60.
13. Haour FG, Ban EM, Marquette C, Rostene W, Tsiang H, Fillion GM: Interleukin-1 receptors in brain and pituitary: Characterization and modulation during infection and stress. NY Acad Sci 1994;741:324-337.
14. Takao T, Culp SG, De Souza EB: Reciprocal modulation of Interleukin-1β (IL-1β) and IL-1 receptors by lipopolysaccharide (endotoxin) treatment in the mouse brain-endocrine-immune axis. Endocrinology 1993;132:1497-1504.
15. Takao T, Nakata H, Tojo C, Kurokawa H, Nishioka T, Hashimoto K, De Souza EB: Regulation of interleukin-1 receptors and hypothalamic-pituitary-adrenal axis by lipopolysaccharide treatment in the mouse. Brain Res 1994;649:265-270.
16. Gabellec MM, Griffais R, Fillion G, Haour F: Interleukin-1 receptors type I and type II in the mouse brain: Kinetics of mRNA expressions after peripheral administration of bacterial lipopolysaccharide. J Neuroimmunol 1996;66:65-75.
17. Ito A, Takii T, Soji T, Onozaki K: Endotoxin-induced upregulation of type I interleukin-1 receptor mRNA expression in hepatocytes of mice: role of cytokines. J Interferon Cytokine Res 1997;17:55-61.
18. Bristulf J, Simoncsits A, Bartfai T: Characterization of a neuronal interleukin-1 receptor and the corresponding mRNA in the mouse anterior pituitary cell line AtT-20. Neurosci Lett 1991;128:173-176.
19. Kobayashi H, Fukata J, Tominaga T, Mura-kami N, Fukushima M, Ebisui O, Segawa H, Nakai Y, Imura H: Regulation of interleukin-1 receptors on AtT-20 mouse pituitary tumour cells. FEBS Lett 1992;298:100-104.
20. De Souza EB, Webster EL, Grigoriadis DE, Tracey DE: Corticotropin-releasing factor (CRF) and interleukin-1 (IL-1) receptors in the brain-pituitary-immune axis. Psychopharmacol Bull 1989;25:299-305.
21. Webster EL, Tracey DE, De Souza EB: Upregulation of interleukin-1 receptors in mouse AtT-20 pituitary tumor cells following treatment with corticotropin-releasing factor. Endocrinology 1991;129:2796-2798.
22. Gallis B, Prickett KS, Jackson J, Slack J, Schooley K, Sims JE, Dower SK: IL-1 induces rapid phosphorylation of the IL-1 receptor. J Immunol 1989;143:3235-3240.
23. Matsushima K, Akahoshi T, Yamada M, Furutani Y, Oppenheim JJ: Properties of a specific interleukin 1 (IL 1) receptor on human Epstein-Barr virus-transformed B lymphocytes: Identity of the receptor for IL 1-alpha and IL 1-beta. J Immunol 1986;136:4496-502.
24. Dower SK, Call SM, Gillis S, Urdal DL: Similarity between the interleukin-1 receptors on a murine T-lymphoma cell line and on a murine fibroblast cell line. Proc Natl Acad Sci USA 1986;83:1060-1064.
25. Nagano I, Takao T, Nanamiya W, Takemura T, Nishiyama M, Asaba K, Makino S, De Souza EB, Hashimoto K: Differential effects of one and repeated endotoxin treatment on pituitary-adrenocortical hormones in the mouse: Role of interleukin-1 and tumor necrosis factor-α. Neuroimmunomodulation 1999;6:284-292.
26. Ito A, Takii T, Goto N, Kito Y, Onozaki K: Role of glucocorticoid in the upregulation of type I interleukin-1 receptor mRNA expression in hepatocytes of endotoxin-administrated mice. J Interferon Cytokine Res 1997;17:413-417.
27. Moreland JG, Fuhrman RM, Wohlford-Lenane CL, Quinn TJ, Benda E, Pruessner JA,Schwartz DA: TNF-alpha and IL-1 beta are not essential to the inflammatory response in LPS-induced airway disease. Am J Physiol Lung Cell Mol Physiol 2001;280:L173-L180.
28. Abraham EJ, Oberst RD, Hays MP, Chapes SK,Minton JE: Effect of endotoxin on interleukin-6 secretion and messenger ribonucleic acid in porcine anterior pituitary cells. Domest Anim Endocrinol 1996;13:491-501.
29. Gloddek J, Lohrer P, Stalla J, Arzt E, Stalla GK, Renner U: The intrapituitary stimulatory effect of lipopolysaccharide on ACTH secretion is mediated by paracrine-acting IL-6. Exp Clin Endocrinol Diabetes 2001;109:410-415.
30. Lohrer P, Gloddek J, Nagashima AC, Korali Z, Hopfner U, Pereda M, Arzt E, Stalla G, Renner U: Lipopolysaccharide directly stimulates the intrapituitary interleukin-6 production by folliculostellate cells via specific receptors and the p38 alpha mitogen-activated protein kinase/nuclear factor-kappaB pathway. Endocrinology 2000;141:4457-4465.
31. 2α receptor regulation and cerebral blood flow of the newborn. Am J Physiol 1997;273:R1283-1290.
32. O'Banion MK: Cyclooxygenase-2:Molecular biology, pharmacology, and neurobiology. Crit Rev Neurobiol 1999;13:45-82.
33. 2 synthesis. Lymphokine Cytokine Res 1994;13:213-219.
34. Aksamit TR, Monick MM, Hunninghake GW: Protein kinase C modulates the amounts of IL-1 receptor mRNA in human lung fibroblasts. J Immunol 1993;151:284-290.
35. Molina-Holgado F, Toulmond S, Rothwell NJ: Involvement of interleukin-1 in glial responses to lipopolysaccharide: Endogenous versus exogenous interleukin-1 actions. J Neuroimmunol 2000;111:1-9.
36. Beckman MJ, Sotos J, Leite F, Schuler LA, Czuprynski CJ: Differential gene regulation of interleukin-1 ligands and receptors in bovine peripheral blood neutrophils and mononuclear cells in response to E. colilipopolysaccharide (LPS). Vet Immunol Immunopathol 2000;77:221-232.
37. Cannon JG, Tompkins RG, Gelfand JA, Michie HR, Stanford GG, van der Meer HWM, Endres S, Lonnemann G, Corsetti J, Chrenow B, Wilmore DW, Wolff SM, Burke JF, Dinarello CA: Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental fever. J Infect Dis 1990;161:79-84.
38. Pollmacher T, Mullington J, Korth C, Schreiber W, Herman D, Prth A, Galanos C, Holsboer F: Diurnal variations in the human host response to endotoxin. J Infect Dis 1996;174:1040-1045.
39. Kluger MJ: Fever: Role of pyrogens and cryogens. Physiol Rev 1991;71:93-127.
40. Chrousos GP: The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 1995;332:1351-1362.
41. Takao T, Dieterich KD, Tracey DE, De Souza EB: Cyclic AMP-dependent modulation of interleukin-1 receptors in the mouse AtT-20 pituitary tumor cell line. Brain Res 1994;656:177-181.